Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,568,120
+$935,690 QoQ
Shares Held
69,174
+1.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#801
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $68,623,451 across 12 Drug Manufacturers - General names. JNJ ranks #2 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437 | $18,515,602 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
69,174 | $17,568,120 | |
| 3 | ABBV |
AbbVie Inc.
|
43,329 | $10,903,309 | |
| 4 | MRK |
Merck & Co., Inc.
|
61,354 | $7,883,989 | |
| 5 | AMGN |
Amgen Inc
|
14,486 | $5,245,670 | |
| 6 | PFE |
Pfizer Inc
|
154,501 | $3,720,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,027 | $1,787,775 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,109 | $1,277,171 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,568,120 | 69,174 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,632,430 | 68,043 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,796,735 | 66,667 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,568,138 | 67,782 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,008,943 | 65,525 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,643,279 | 64,178 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,938,720 | 68,723 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $10,872,767 | 67,091 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,650,067 | 66,024 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,750,750 | 67,961 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $10,262,238 | 65,473 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $10,509,231 | 67,475 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $11,357,320 | 68,616 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,499,545 | 67,739 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,673,032 | 66,080 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $9,845,053 | 60,266 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,808,938 | 60,892 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,287,029 | 52,401 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $8,453,937 | 49,418 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,844,055 | 48,570 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,469,942 | 51,414 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,157,019 | 49,632 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,686,004 | 17,067 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,438,952 | 16,382 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,317,019 | 16,476 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,011,009 | 15,336 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||